Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma. [electronic resource]
Producer: 20180717Description: 2157-2165 p. digitalISSN:- 1538-8514
- Aminopyridines -- administration & dosage
- Animals
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Humans
- Imidazoles -- administration & dosage
- Liver Cirrhosis -- drug therapy
- Liver Neoplasms -- drug therapy
- Niacinamide -- administration & dosage
- Oncogene Protein v-akt -- antagonists & inhibitors
- Phenylurea Compounds -- administration & dosage
- Rats
- Signal Transduction -- drug effects
- Sorafenib
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.